Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of Cigna Group
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001739940.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
12 May 2026
- Public ticker
- CI on NYSE
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- VANGUARD CAPITAL MANAGEMENT LLC
- Latest 13D/G holder
- VANGUARD CAPITAL MANAGEMENT LLC
- Latest parsed ownership date
- 12 May 2026
- Issuer CIK
- 0001739940
- Issuer location
- Bloomfield, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Cigna Group (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
12 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.5%
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.5%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
BlackRock, Inc.
7.4%
FMR LLC
4%
David Cordani
0.25%
Eric J. Foss
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$5,285,500,003
19,814,433 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
7.4%
|
$6,687,563,331
19,941,446 shares
|
$0 | 31 Mar 2025 |
| FMR LLC |
13D/G
13F
Company
|
4%
|
$3,074,346,505
10,665,556 shares
|
$0 | 30 Sep 2025 |
| David Cordani |
3/4/5
Chairman & CEO, Director
|
0.25%
|
$175,602,095
658,302 shares
|
-$58,114,270 | 12 May 2026 |
| Eric J. Foss |
3/4/5
Director
|
0.01%
|
$9,788,661
36,696 shares
|
— | 22 Apr 2026 |
| Donna F. Zarcone |
3/4/5
Director
|
0.01%
|
$7,340,162
27,517 shares
|
— | 22 Apr 2026 |
| Kathleen M. Mazzarella |
3/4/5
Director
|
0%
|
$1,838,174
6,891 shares
|
— | 22 Apr 2026 |
| Mark B. McClellan |
3/4/5
Director
|
0%
|
$1,838,174
6,891 shares
|
— | 22 Apr 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$69,445,622.
Buys
$999,916
Insiders: 1
Sells
$70,445,538
Insiders: 4
Net
-$69,445,622
Shares: -235,664
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 4,134
Shares: 239,798
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 201,878 | $0 | $59,114,186 | -$59,114,186 |
| 3-6 | 0 | 4,026 | $0 | $1,163,152 | -$1,163,152 |
| 6-9 | 4,134 | 5,368 | $999,916 | $1,610,400 | -$610,484 |
| 9-12 | 0 | 28,526 | $0 | $8,557,800 | -$8,557,800 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 34 reporting-owner rows connected to Cigna Group. Open a relationship link for the CIK-to-CIK filing trail.
Rows
34
Largest Forms 3/4/5 holder
David Cordani
Net 12M change
-$69,445,621
Latest report
01 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David Cordani | Chairman & CEO, Director | $175,602,095 | -$58,114,270 | -25% | Median | 12 May 2026 |
| Eric P. Palmer | Officer | $20,768,093 | Mixed | 28 Feb 2025 | ||
| Brian C. Evanko | Officer | $18,531,357 | -$1,610,400 | -8% | Mixed | 27 Feb 2026 |
| Timothy C. Wentworth | CEO Evernorth | $17,480,701 | Mixed | 12 May 2021 | ||
| John M. Murabito | EVP & Chief Admin Officer | $15,685,605 | Mixed | 01 Mar 2022 | ||
| Michael W. Triplett | Special Advisor | $13,521,895 | Mixed | 12 Aug 2024 | ||
| Jason D. Sadler | Pres., International Health | $13,414,320 | Mixed | 24 Feb 2023 | ||
| Matthew G. Manders | Pres, Government and Solutions | $12,407,996 | Mixed | 19 Nov 2021 | ||
| Nicole S. Jones | Officer | $9,844,703 | -$9,224,315 | -48% | Mixed | 27 Feb 2026 |
| Eric J. Foss | Director | $9,788,661 | Median | 22 Apr 2026 | ||
| Eric C. Wiseman | Director | $9,167,972 | Mixed | 22 Apr 2026 | ||
| John Partridge | Director | $8,501,680 | Mixed | 26 Apr 2022 | ||
| Donna F. Zarcone | Director | $7,340,162 | Median | 22 Apr 2026 | ||
| William J. DeLaney III | Director | $6,010,265 | Filing P/S | 19 Aug 2024 | ||
| Isaiah Harris Jr. | Director, Chairman of the Board | $5,710,680 | Mixed | 30 Nov 2021 | ||
| David J. Brailer | EVP & Chief Health Officer | $5,269,066 | Mixed | 29 Aug 2025 | ||
| Noelle K. Eder | EVP, Global Chief Information Officer | $4,348,906 | Mixed | 07 Mar 2025 | ||
| Paul A. Sanford | EVP Operations | $2,550,925 | Mixed | 19 Jul 2023 | ||
| Ann M. Dennison | Evp, Cfo | $2,227,074 | Mixed | 27 Feb 2026 | ||
| Cynthia Ryan | Evp, Chro | $2,184,555 | Mixed | 29 Aug 2023 |
Recent insider transactions for Cigna Group
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Durga Prasad Koka | CI | Common Stock, $.01 Par Value | Tax liability | -10% | -729 | 6,552 | 01 Jun 2026 | Direct | ||
| George Kurian | CI | Phantom Stock Units | Award | 5.96% | 108 | 1,922 | 29 May 2026 | Direct | ||
| David Cordani | CI | Common Stock, $.01 Par Value | Options Exercise | 68.2% | 23,429 | 57,766 | 13 May 2026 | Direct | ||
| David Cordani | CI | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -23,429 | 0 | 13 May 2026 | Direct | ||
| David Cordani | CI | Common Stock, $.01 Par Value | Sale | -85.5% | $59,114,186 | $292.82 | -201,878 | 34,337 | 12 May 2026 | Direct |
| David Cordani | CI | Common Stock, $.01 Par Value | Options Exercise | 401.5% | 189,114 | 236,215 | 12 May 2026 | Direct | ||
| David Cordani | CI | Employee Stock Option (Right to Buy) | Options Exercise | -96% | -189,114 | 7,971 | 12 May 2026 | Direct | ||
| Eric J. Foss | CI | Common Stock, $.01 Par Value | Award | 2.18% | 782 | 36,696 | 22 Apr 2026 | Direct | ||
| Mark B. McClellan | CI | Common Stock, $.01 Par Value | Award | 12.8% | 782 | 6,891 | 22 Apr 2026 | Direct | ||
| Neesha Hathi | CI | Common Stock, $.01 Par Value | Award | 23.2% | 782 | 4,151 | 22 Apr 2026 | Direct | ||
| Donna F. Zarcone | CI | Common Stock, $.01 Par Value | Award | 2.93% | 782 | 27,517 | 22 Apr 2026 | Direct | ||
| Kathleen M. Mazzarella | CI | Common Stock, $.01 Par Value | Award | 12.8% | 782 | 6,891 | 22 Apr 2026 | Direct | ||
| George Kurian | CI | Common Stock, $.01 Par Value | Award | 20.7% | 782 | 4,560 | 22 Apr 2026 | Direct | ||
| Kimberly A. Ross | CI | Common Stock, $.01 Par Value | Award | 17.3% | 782 | 5,294 | 22 Apr 2026 | Direct | ||
| Michael J. Hennigan | CI | Common Stock, $.01 Par Value | Award | 137.7% | 782 | 1,350 | 22 Apr 2026 | Direct | ||
| Philip Ozuah | CI | Common Stock, $.01 Par Value | Award | 43.4% | 782 | 2,583 | 22 Apr 2026 | Direct | ||
| Eric C. Wiseman | CI | Common Stock, $.01 Par Value | Award | 3.38% | 782 | 23,940 | 22 Apr 2026 | Direct | ||
| Everett Neville | CI | Common Stock, $.01 Par Value | Sale | -23.3% | $496,636 | $288.91 | -1,719 | 5,670 | 02 Mar 2026 | Direct |
| Nicole S. Jones | CI | Common Stock, $.01 Par Value | Sale | -6.6% | $666,515 | $288.91 | -2,307 | 32,647 | 02 Mar 2026 | Direct |
| Jamie G. Kates | CI | Common Stock, $.01 Par Value | Tax liability | -5.28% | -132 | 2,368 | 27 Feb 2026 | Direct | ||
| Jamie G. Kates | CI | Common Stock, $.01 Par Value | Award | 48.3% | 814 | 2,500 | 27 Feb 2026 | Direct | ||
| Jamie G. Kates | CI | Employee Stock Option (Right to Buy) | Award | 657 | 657 | 27 Feb 2026 | Direct | |||
| Durga Prasad Koka | CI | Common Stock, $.01 Par Value | Tax liability | -2.93% | -220 | 7,281 | 27 Feb 2026 | Direct | ||
| Durga Prasad Koka | CI | Common Stock, $.01 Par Value | Award | 73.5% | 3,177 | 7,501 | 27 Feb 2026 | Direct | ||
| Durga Prasad Koka | CI | Employee Stock Option (Right to Buy) | Award | 4,127 | 4,127 | 27 Feb 2026 | Direct | |||
| Everett Neville | CI | Common Stock, $.01 Par Value | Tax liability | -15.9% | -1,400 | 7,389 | 27 Feb 2026 | Direct | ||
| Everett Neville | CI | Common Stock, $.01 Par Value | Award | 150.5% | 5,280 | 8,789 | 27 Feb 2026 | Direct | ||
| Everett Neville | CI | Employee Stock Option (Right to Buy) | Award | 4,127 | 4,127 | 27 Feb 2026 | Direct | |||
| Nicole S. Jones | CI | Common Stock, $.01 Par Value | Tax liability | -7.26% | -2,738 | 34,954 | 27 Feb 2026 | Direct | ||
| Nicole S. Jones | CI | Common Stock, $.01 Par Value | Award | 33.1% | 9,367 | 37,692 | 27 Feb 2026 | Direct | ||
| Nicole S. Jones | CI | Employee Stock Option (Right to Buy) | Award | 8,066 | 8,066 | 27 Feb 2026 | Direct | |||
| Brian C. Evanko | CI | Common Stock, $.01 Par Value | Tax liability | -11.2% | -4,767 | 37,917 | 27 Feb 2026 | Direct | ||
| Brian C. Evanko | CI | Common Stock, $.01 Par Value | Award | 61.3% | 16,215 | 42,684 | 27 Feb 2026 | Direct | ||
| Brian C. Evanko | CI | Employee Stock Option (Right to Buy) | Award | 15,082 | 15,082 | 27 Feb 2026 | Direct | |||
| Ann M. Dennison | CI | Common Stock, $.01 Par Value | Tax liability | -5.02% | -409 | 7,745 | 27 Feb 2026 | Direct | ||
| Ann M. Dennison | CI | Common Stock, $.01 Par Value | Award | 179.2% | 5,234 | 8,154 | 27 Feb 2026 | Direct | ||
| Ann M. Dennison | CI | Employee Stock Option (Right to Buy) | Award | 8,066 | 8,066 | 27 Feb 2026 | Direct | |||
| David Cordani | CI | Common Stock, $.01 Par Value | Tax liability | -24.7% | -15,432 | 47,101 | 27 Feb 2026 | Direct | ||
| David Cordani | CI | Common Stock, $.01 Par Value | Award | 192.8% | 41,177 | 62,533 | 27 Feb 2026 | Direct | ||
| David Cordani | CI | Employee Stock Option (Right to Buy) | Award | 37,516 | 37,516 | 27 Feb 2026 | Direct | |||
| George Kurian | CI | Phantom Stock Units | Award | 6.09% | 104 | 1,804 | 27 Feb 2026 | Direct | ||
| George Kurian | CI | Phantom Stock Units | Award | 6.84% | 108 | 1,691 | 28 Nov 2025 | Direct | ||
| David Cordani | CI | Common Stock, $.01 Par Value | Purchase | 2.69% | $999,916 | $241.88 | 4,134 | 157,935 | 03 Nov 2025 | By Trust |
| Brian C. Evanko | CI | Common Stock, $.01 Par Value | Options Exercise | 1.76% | 901 | 52,083 | 06 Oct 2025 | Direct | ||
| Brian C. Evanko | CI | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -901 | 0 | 06 Oct 2025 | Direct | ||
| Brian C. Evanko | CI | Common Stock, $.01 Par Value | Sale | -9.49% | $1,610,400 | $300.00 | -5,368 | 51,182 | 03 Oct 2025 | Direct |
| Brian C. Evanko | CI | Common Stock, $.01 Par Value | Options Exercise | 10.5% | 5,368 | 56,550 | 03 Oct 2025 | Direct | ||
| Brian C. Evanko | CI | Employee Stock Option (Right to Buy) | Options Exercise | -85.6% | -5,368 | 901 | 03 Oct 2025 | Direct | ||
| George Kurian | CI | Phantom Stock Units | Award | 6.76% | 99.71 | 1,575 | 29 Aug 2025 | Direct | ||
| David J. Brailer | CI | Common Stock, $.01 Par Value | Tax liability | -1.63% | -290 | 17,525 | 29 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.